Inactive Instrument

Ergomed

Equities

ERGO

GB00BN7ZCY67

Biotechnology & Medical Research

Ergomed : Board Appointment

June 18, 2019 at 10:19 am EDT

Chiltern Clinical Research (Philippines) Inc.

Chiltern Clinical Research KK

Chiltern Clinical Research S.R.L.

Chiltern Clinical Research YH

Chiltern International (Canada) Ltd.

Chiltern International (Hong Kong) Ltd.

Chiltern International AB

Chiltern International B.V.

Chiltern International BVBA/Sprl

Chiltern International EOOD

Chiltern International GmbH

CHILTERN INTERNATIONAL GROUP LIMITED

CHILTERN INTERNATIONAL HOLDINGS LIMITED

Chiltern International Inc.

Chiltern International Kft

CHILTERN INTERNATIONAL LIMITED⁽¹⁾

Chiltern International Ltd.⁽²⁾

Chiltern International Portugal Lda

Chiltern International Pte Ltd

Chiltern International Pty. Ltd.

Chiltern International Pvt. Ltd.

Chiltern International SARL

Chiltern International SP Zoo

Chiltern International Spain SA

Chiltern International SRL⁽³⁾

Chiltern International SRL⁽⁴⁾

Chiltern International sro

Chiltern International Switzerland SARL

Chiltern International Taiwan Ltd.

Chiltern Klinik Arastirma Organizayson Limited Sirketi

Chiltern Pharmaceutical and Technology Consulting (Shanghai) Co. Ltd.

Chiltern Research International (Singapore) Ltd.

Chiltern Research International Pty. Ltd.

Covance Clinical Development GmbH

ENDPOINT CLINICAL (UK) LTD

Endpoint Clinical India Private Limited

Endpoint Clinical, Inc.

HAVENFERN LIMITED

Integrated Development Associates Co., Ltd.

OCKHAM DEVELOPMENT GROUP (HOLDINGS) UK LIMITED

Ockham Development Group Inc.

OCKHAM EUROPE LIMITED

Ockham India Clinical Research and Data Services Pvt. Ltd.

Ockham Oncology AB

Ockham Oncology GmbH

Ockham Oncology Kft

Ockham Oncology Pty. Ltd.

Ockham Oncology S.L.U.

Ockham Oncology SPRL (Belgium)

Pacific Clinical Research India Limited

TCR International B.V.

TCR Latin America B.V.

Theorem Clinical Research Holdings B.V.

Theorem Clinical Research Holdings Inc.

Theorem Clinical Research Inc.

Theorem Clinical Research Kft

THEOREM CLINICAL RESEARCH LIMITED

Theorem Clinical Research Pte. Ltd.⁽⁵⁾

Theorem Clinical Research Pte. Ltd.⁽⁶⁾

Theorem Clinical Research Pty Ltd

Theorem Clinical Research SARL

Theorem Clinical Research SRL

Theorem Clinical Research sro

Theorem CR Inc.

Theorem Foreign Representation Company

Theorem Research Associates, Inc.

Attachments

Original document
Permalink

Disclaimer

Ergomed plc published this content on 18 June 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 June 2019 14:18:07 UTC

Latest news about Ergomed

Ergomed Delists From London Stock Exchange	Nov. 14	MT
Permira Advisers Ltd. completed the acquisition of Ergomed plc from Amati Global Investors Ltd. and others.	Nov. 12	CI
Milton plans energy focus; Guild completes fund raise	Nov. 09	AN
UK Court Clears Permira's Ergomed Purchase	Nov. 09	MT
Ergomed says conditions satisfied for Permira takeover	23-10-27	AN
Permira's Takeover of Ergomed Nears Completion	23-10-27	MT
Ergomed's Takeover by Permira Advisers Expected to Take Effect mid-November	23-10-23	MT
Ergomed Shareholders Back Eden AcquisitionCo's Bid	23-10-13	MT
Ergomed plc acquired Panacea Pharma Projects Limited from Stuart Colligon.	23-10-09	CI
The FTSE 100 Closed Up as UK Retail Sales, Consumer Confidence Data Offers Economic Hope	23-09-22	DJ
Ergomed first-half profit firms ahead of agreed takeover by Permira	23-09-22	AN
Ergomed Posts Flat H1 Profit; Revenue Rises	23-09-22	MT
Earnings Flash (ERGO.L) ERGOMED Posts H1 Revenue GBP76.7M	23-09-22	MT
Ergomed plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-22	CI
FTSE 100 Closes Modestly Lower on Asia Caution	23-09-04	DJ
Stocks wilt after early promise with US closed	23-09-04	AN
British Land Shares Lack Drivers as City Valuations Dip	23-09-04	DJ
ANALYST RECOMMENDATIONS : Ergomed, Dollar general, Salesforce, Citigroup, Goldman Sachs...	23-09-04
AIM WINNERS & LOSERS: Physiomics brings in COO; Ergomed receives bid	23-09-04	AN
Ergomed agrees GBP700 million takeover by Permira	23-09-04	AN
Stocks lifted by hopes for US rate pause	23-09-04	AN
Ergomed Agrees GBP703 Million Takeover by Permira Funds	23-09-04	MT
CMC names new CFO; takeover offer for Ergomed	23-09-04	AN
Permira Advisers Ltd. entered into a scheme of arrangement to acquire Ergomed plc for approximately £700 million.	23-09-03	CI
FTSE 100 Closes Tuesday Up 0.2% Lifted by Unilever, Miners	23-07-25	DJ

Chart Ergomed

Duration

Period

More charts

Company Profile

Ergomed PLC is a United Kingdom-based company that is primarily focused on providing specialized services to the biopharmaceutical industry. The Company operates through two segments: Clinical Research Services (CRO) and Pharmacovigilance (PV). Its CRO segment is the process of developing medical therapies, drugs and knowledge for safe use in healthcare. Its PV segment is engaged in the activities relating to the detection, understanding and prevention of adverse effects or other drug-related problems throughout its lifecycle. The Company serves over 100 countries. It operates in North America, United Kingdom and Europe, Middle East and Africa, and Asia. The Companies subsidiaries include PrimeVigilance Inc., PrimeVigilance USA Inc., PrimeVigilance s.r.o., PharmInvent regulatory s.r.o., PrimeVigilance Japan K.K., Haemostatix Limited and Sound Opinion Limited.

Sector

Biotechnology & Medical Research

Calendar

2024-09-23 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+3.91%	109B
REGENERON PHARMACEUTICALS, INC.	+10.87%	105B
ARGENX SE	+1.28%	22.25B
BIONTECH SE	-13.14%	22.09B
GENMAB A/S	-7.05%	18.68B
WUXI APPTEC CO., LTD.	-38.36%	17.58B
BEIGENE, LTD.	-10.66%	16.85B
NEUROCRINE BIOSCIENCES, INC.	+3.75%	13.76B
SAREPTA THERAPEUTICS, INC.	+36.70%	12.46B

Bio Therapeutic Drugs